This site is intended for healthcare professionals
Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria Learning Zone
Declaration of sponsorship Novartis Pharma AG

Patient perspectives

Declaration of sponsorship Novartis Pharma AG
Read time: 20 mins
Last updated:21st Feb 2023
Published:21st Feb 2023

Patient perspectives on chronic spontaneous urticaria

Arzoo Ahmed (Head of Ethics, Our Future Health, UK) and Elaine Dery (President, Canadian Patient Association; Global Allergy and Airways Patient Platform [GAAPP]) offer valuable insight on what it is like to live with chronic spontaneous urticaria (CSU).

Arzoo and Elaine discuss their treatment experiences, the importance of patient representatives at major congresses, such as GUF 2022, advice for physicians managing CSU, among other important topics. View their introductions here.

How does GAAP empower patients and improve patient management in CSU?
What advice would you give to primary and secondary physicians for managing CSU?

Global Allergy & Airways Patient Platform

A Shared Decision-Making Tool can help your Healthcare Provider learn more about where you are at with your CSU/CIU, and work with you to come up with or alter your management plan so that it meets your specific needs and goals.

View external site

Watch Global Urticaria Forum 2022 highlights